The first new Alzheimer's drug in decades costs $56,000, probably doesn't work, and could stand in the way of better treatmentsBusiness InsiderNov 28, 2022
FDA’s new regulations underscore the complexity around screening for women with dense breastsThe ConversationSep 28
For COVID Drugs, Months of Frantic Development Lead to Few Outright SuccessesScientific AmericanNov 28, 2020